Propranolol reduces portal vein diameter in schistosomal liver disease with portal hypertension a prospective cohort study- Edford Sinkala

Conference on Liver Disease in Africa (COLDA) 2020

Particularities of HCC in Africa - Lewis Roberts

Conference on Liver Disease in Africa (COLDA) 2020

Resistance du VHB aux inhibiteurs nucleostidiques de la transcriptase inverse INTI et son impact sur l'aantigene de surface AgHBs chez des patients co-infectes VHB-VIH a Abidjan -Leto Olivier Gogbe

Conference on Liver Disease in Africa (COLDA) 2020

Seroprevalence and molecular epidemiology of hepatitis C in Malawi a cross-sectional community census-based serological survey of Ndriande Blantyre - Alexander Stockdale

Conference on Liver Disease in Africa (COLDA) 2020

Viral hepatitis B & C elimination in 2030-Lesi Olufunmilayo

Conference on Liver Disease in Africa (COLDA) 2020

Access to treatment in Africa_-Oriel Fernandes

Conference on Liver Disease in Africa (COLDA) 2020

Assessment of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in Ethiopia - Hailemichael Desalegn

Conference on Liver Disease in Africa (COLDA) 2020

Birth dose vaccination and screening of pregnant women -Maud Lemoine

Conference on Liver Disease in Africa (COLDA) 2020

Community experience while delivering hepatitis B services during the pandemic -Arafat Bwambale

Conference on Liver Disease in Africa (COLDA) 2020

DNA methyltransferases as potential biomarkers of HCV related hepatocellular carcinoma - Mona Hassouna

Conference on Liver Disease in Africa (COLDA) 2020

Frequency of occult hepatitis B virus among blood donors in Khartoum state Sudan a preliminary study - Mustafa Yassin

Conference on Liver Disease in Africa (COLDA) 2020

Scientific Report - International Conference on HIV Treatment, Pathogenesis, and Prevention Research (INTEREST) 2019 - Ian Grubb

PrEP - Overcoming Challenges - Lessons from Asia - Donn Colby, MD, MPH

European Workshop on Healthy Living with HIV 2019

PrEP Rollout in Europe - Current Update - Pep Coll, MD

European Workshop on Healthy Living with HIV 2019

PrEP - remaining community needs - Michael Meulbroek

European Workshop on Healthy Living with HIV 2019

What are the remaining challenges to improve the quality of life of people living HIV? - Michael Meulbroek

European Workshop on Healthy Living with HIV 2019

ChemSex - DDI interactions - Jose Molto, MD, PhD

European Workshop on Healthy Living with HIV 2019

The relationship between the migration status and the Health-Related Quality of Life (HRQoL) of people living with HIV: a study on the Swedish InfcareHIV cohort from 2011 to 2017 - Gaetano Marrone

European Workshop on Healthy Living with HIV 2019

Sexual Health Counseling - Shaun Watson

European Workshop on Healthy Living with HIV 2019

Country specific factors determine the quality of life among people with HIV in two western European countries - Stephanie Popping, MD

European Workshop on Healthy Living with HIV 2019

An online survey of the quality of life in patients with HIV-infection in Krasnodar - Maxim Konyukhov

European Workshop on Healthy Living with HIV 2019

HIV and Ageing – Primary and secondary prevention of coronary artery disease among People living with HIV - Gaetano Marrone

European Workshop on Healthy Living with HIV 2019

Very low sensitivity of Fracture Risk Assessment Tool in young HIV-infected patients: The need for new screening strategies - Berend van Welzen, MD

European Workshop on Healthy Living with HIV 2019

Current status of HIV: the importance of comorbidities. Do we have to worry about the quality of life of our HIV patients? - Maria Jose Galindo

European Workshop on Healthy Living with HIV 2019